Drug intelligence / Profile preview

AL7182

Development stage: Unknown
Modality: Small Molecules

Overview

AL7182 is a chemical compound identified by PubChem CID 1604, classified as a pharmaceutical. Its molecular formula is C13H14N2O5S3, and it has a molecular weight of 374.5 g/mol, suggesting it is a small molecule. Specific details regarding its mechanism of action, primary indication, developer, and development status are not readily available in public databases.

Other names: 2-(3-methoxyphenyl)-1,1-dioxo-3,4-dihydrothieno[3,2-e]thiazine-6-sulfonamideICIXQGGQPKFQRL-UHFFFAOYSA-NCOC1=CC=CC(=C1)N2CCC3=C(S2(=O)=O)SC(=C3)S(=O)(=O)N

Beyond the preview

Go deeper on AL7182.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AL7182.

Explore the full profile